225 related articles for article (PubMed ID: 18198220)
1. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
Christ-Crain M; Kola B; Lolli F; Fekete C; Seboek D; Wittmann G; Feltrin D; Igreja SC; Ajodha S; Harvey-White J; Kunos G; Müller B; Pralong F; Aubert G; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
FASEB J; 2008 Jun; 22(6):1672-83. PubMed ID: 18198220
[TBL] [Abstract][Full Text] [Related]
2. CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus.
Scerif M; Füzesi T; Thomas JD; Kola B; Grossman AB; Fekete C; Korbonits M
J Endocrinol; 2013 Oct; 219(1):79-88. PubMed ID: 23884964
[TBL] [Abstract][Full Text] [Related]
3. Long-term exercise stimulates adenosine monophosphate-activated protein kinase activity and subunit expression in rat visceral adipose tissue and liver.
Takekoshi K; Fukuhara M; Quin Z; Nissato S; Isobe K; Kawakami Y; Ohmori H
Metabolism; 2006 Aug; 55(8):1122-8. PubMed ID: 16839850
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits adenosine 5'-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons.
Chau-Van C; Gamba M; Salvi R; Gaillard RC; Pralong FP
Endocrinology; 2007 Feb; 148(2):507-11. PubMed ID: 17095593
[TBL] [Abstract][Full Text] [Related]
5. Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase.
Brown KA; Hunger NI; Docanto M; Simpson ER
Breast Cancer Res Treat; 2010 Sep; 123(2):591-6. PubMed ID: 20300828
[TBL] [Abstract][Full Text] [Related]
6. Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression.
Viana AY; Sakoda H; Anai M; Fujishiro M; Ono H; Kushiyama A; Fukushima Y; Sato Y; Oshida Y; Uchijima Y; Kurihara H; Asano T
Diabetes Res Clin Pract; 2006 Aug; 73(2):135-42. PubMed ID: 16503364
[TBL] [Abstract][Full Text] [Related]
7. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
Kola B; Christ-Crain M; Lolli F; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Dec; 93(12):4969-73. PubMed ID: 18782871
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
9. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J
J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429
[TBL] [Abstract][Full Text] [Related]
10. Appetite and metabolic effects of ghrelin and cannabinoids: involvement of AMP-activated protein kinase.
van Thuijl H; Kola B; Korbonits M
Vitam Horm; 2008; 77():121-48. PubMed ID: 17983855
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of dyslipidemia in Cushing's syndrome.
Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
[TBL] [Abstract][Full Text] [Related]
12. Lack of starvation-induced activation of AMP-activated protein kinase in the hypothalamus of the Lou/C rats resistant to obesity.
Taleux N; De Potter I; Deransart C; Lacraz G; Favier R; Leverve XM; Hue L; Guigas B
Int J Obes (Lond); 2008 Apr; 32(4):639-47. PubMed ID: 18059408
[TBL] [Abstract][Full Text] [Related]
13. Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity.
Gonzalez AA; Kumar R; Mulligan JD; Davis AJ; Weindruch R; Saupe KW
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E1032-7. PubMed ID: 15251868
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.
Kola B; Hubina E; Tucci SA; Kirkham TC; Garcia EA; Mitchell SE; Williams LM; Hawley SA; Hardie DG; Grossman AB; Korbonits M
J Biol Chem; 2005 Jul; 280(26):25196-201. PubMed ID: 15899896
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5' monophosphate-activated protein kinase (AMPK).
Tosca L; Chabrolle C; Uzbekova S; Dupont J
Biol Reprod; 2007 Mar; 76(3):368-78. PubMed ID: 17123942
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase and the metabolic syndrome.
Fryer LG; Carling D
Biochem Soc Trans; 2005 Apr; 33(Pt 2):362-6. PubMed ID: 15787607
[TBL] [Abstract][Full Text] [Related]
17. Expanding role of AMPK in endocrinology.
Kola B; Boscaro M; Rutter GA; Grossman AB; Korbonits M
Trends Endocrinol Metab; 2006 Jul; 17(5):205-15. PubMed ID: 16766204
[TBL] [Abstract][Full Text] [Related]
18. Chronic activation of AMP-activated kinase as a strategy for slowing aging.
McCarty MF
Med Hypotheses; 2004; 63(2):334-9. PubMed ID: 15236799
[TBL] [Abstract][Full Text] [Related]
19. Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases.
Kewalramani G; Puthanveetil P; Kim MS; Wang F; Lee V; Hau N; Beheshti E; Ng N; Abrahani A; Rodrigues B
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E137-47. PubMed ID: 18460599
[TBL] [Abstract][Full Text] [Related]
20. Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis.
Kefas BA; Cai Y; Kerckhofs K; Ling Z; Martens G; Heimberg H; Pipeleers D; Van de Casteele M
Biochem Pharmacol; 2004 Aug; 68(3):409-16. PubMed ID: 15242807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
